Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review

[1]  Sudhir V. Shah,et al.  Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[2]  H. Kalim,et al.  Transforming growth factor β1 is better than α smooth muscle actin for the prediction of renal fibrosis in patients with nephritic lupus , 2015 .

[3]  D. Siscovick,et al.  Urine Collagen Fragments and CKD Progression-The Cardiovascular Health Study. , 2015, Journal of the American Society of Nephrology : JASN.

[4]  M. Li,et al.  Urinary serum‐ and glucocorticoid‐inducible kinase SGK1 reflects renal injury in patients with immunoglobulin A nephropathy , 2014, Nephrology.

[5]  J. Olivo-Marin,et al.  Urinary Retinol Binding Protein Is a Marker of the Extent of Interstitial Kidney Fibrosis , 2014, PloS one.

[6]  Xiaoxiang Chen,et al.  Urinary TGF-1 has a supplementary value in predicting renal function recovery post unilateral ureteral obstruction , 2014, International Urology and Nephrology.

[7]  M. Franco,et al.  Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy. , 2013, Transplant immunology.

[8]  L. Qu,et al.  Evaluation of Urinary Biomarkers for the Prognosis of Drug-associated Chronic Tubulointerstitial Nephritis , 2013, The American journal of the medical sciences.

[9]  J. Wetzels,et al.  Urinary Connective Tissue Growth Factor Is Associated with Human Renal Allograft Fibrogenesis , 2013, Transplantation.

[10]  J. Bouchard,et al.  Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study. , 2013, Diabetes research and clinical practice.

[11]  D. Tarng,et al.  Progression of Kidney Disease in Non-Diabetic Patients with Coronary Artery Disease: Predictive Role of Circulating Matrix Metalloproteinase-2, -3, and -9 , 2013, PloS one.

[12]  A. Garg,et al.  Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[13]  T. Larson,et al.  Urine High and Low Molecular Weight Proteins One‐Year Post‐Kidney Transplant: Relationship to Histology and Graft Survival , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  M. Woodward,et al.  Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. , 2013, Kidney international.

[15]  Hong Zhang,et al.  Increased plasma sVCAM-1 is associated with severity in IgA nephropathy , 2013, BMC Nephrology.

[16]  S. Titan,et al.  Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy. , 2012, Journal of diabetes and its complications.

[17]  Y. Jiang,et al.  Urinary mannose‐binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy , 2012, Clinical and experimental immunology.

[18]  P. Reese,et al.  Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes: a systematic review. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  Y. Fukuda,et al.  Involvement of matrix metalloproteinase-2 in the development of renal interstitial fibrosis in mouse obstructive nephropathy , 2012, Laboratory Investigation.

[20]  H. Nagaraja,et al.  A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. , 2012, Kidney international.

[21]  K. Salmela,et al.  Donor risk score and baseline biopsy CADI value predict kidney graft outcome , 2011, Clinical transplantation.

[22]  A. Garg,et al.  Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. , 2011, Journal of the American Society of Nephrology : JASN.

[23]  R. Gebhardt,et al.  Cardiovascular , Pulmonary and Renal Pathology Tubular Overexpression of Transforming Growth Factor-1 Induces Autophagy and Fibrosis but Not Mesenchymal Transition of Renal Epithelial Cells , 2010 .

[24]  J. Olivo-Marin,et al.  Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[25]  Sandrine Florquin,et al.  The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. , 2009, Kidney international.

[26]  Shun-Fa Yang,et al.  Prediction of chronic allograft damage index of renal allografts using serum level of plasminogen activator inhibitor‐1 , 2009, Clinical transplantation.

[27]  Vicente de Paulo Castro Teixeira,et al.  Relative Contribution of Morphometric and Functional Indicators of Tubulointerstitial Lesion to Glomerular Diseases Prognosis , 2008, Nephron Clinical Practice.

[28]  E. Bonifacio,et al.  High Levels of Donor CCL2/MCP‐1 Predict Graft‐Related Complications and Poor Graft Survival After Kidney‐Pancreas Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  G. Einecked,et al.  Banff 07 Classification of Renal Allograft Pathology : Updates and Future Directions , 2008 .

[30]  C. Kallenberg,et al.  Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis. , 2007, American journal of physiology. Renal physiology.

[31]  S. Roberts,et al.  TGF-beta1 in chronic allograft nephropathy following renal transplantation. , 2007, Journal of nephrology.

[32]  H. Nagaraja,et al.  Clinical risk factors associated with bleeding after native kidney biopsy , 2005, Nephrology.

[33]  Eun Sun Lee,et al.  Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  L. Gesualdo,et al.  Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. , 2004, Kidney international.

[35]  K. Matsushima,et al.  Blockade of CCR2 ameliorates progressive fibrosis in kidney. , 2004, The American journal of pathology.

[36]  A. Teppo,et al.  Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients , 2003, Transplantation.

[37]  David Moher,et al.  The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration , 2003, Annals of Internal Medicine [serial online].

[38]  M S Pepe,et al.  Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.

[39]  D. Poppas,et al.  Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. , 2000, Kidney international.

[40]  P. Groop,et al.  Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[41]  C. Brown,et al.  Urinary and serum type III collagen: markers of renal fibrosis. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  K. Yoshioka,et al.  Urinary transforming growth factor-β in patients with glomerular diseases , 1997, Pediatric Nephrology.

[43]  E. Cohen,et al.  Fibrosis causes progressive kidney failure. , 1995, Medical hypotheses.

[44]  F. Strutz.  Novel aspects of renal fibrogenesis. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[45]  M C Buer,et al.  The general population. , 2022, The Eugenics review.